Tourmaline Bio, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
Tourmaline Bio, Inc. has filed a definitive proxy statement with the SEC, indicating upcoming shareholder actions.
Tourmaline Bio will hold its annual stockholder meeting virtually on June 4, 2025, to elect directors and ratify the selection of its independent auditor.
Tourmaline Bio, Inc. has filed a definitive proxy statement with the SEC related to its upcoming shareholder meeting.
Tourmaline Bio will hold its Annual Meeting of Stockholders virtually on June 5, 2024, to elect directors and ratify the selection of its independent accounting firm.